About Jeb Keiper
Jeb Keiper is an independent board director at Strand Therapeutics.
Form D filings also name Jeb Keiper as a director at Cardurion Pharmaceuticals.
Jeb Keiper first appears on SEC filings in 2019.
Experience
This experience comes from Jeb Keiper's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jeb Keiper in the role, so the role may have started earlier or lasted longer.
TV
Third Rock Ventures Current
Venture Partner
2026 – Present
Strand Therapeutics Inc. Current
Independent Board Director
Director Board of Directors (2025 – Present)
2025 – Present · Boston, MA
Develops mRNA medicines for people with cancer and autoimmune diseases.
RT
ROME Therapeutics
Board Member
2019 – 2026
NT
Nimbus Therapeutics
Former Chief Executive Officer
2014 – 2026
GL
GlaxoSmithKline
VP, Business Development, GSK Oncology
2005 – 2014
MC
McKinsey & Co.
Engagement Manager
2000 – 2005
TP
TransForm Pharmaceuticals
Business Development Manager
2003 – 2004
MH
Massachusetts General Hospital
Pharmacy Pharmacoeconomic Analyst
2002 – 2003
MC
Mitsubishi Chemical Company
Engineering Consultant
2000
PF
Pfizer
Scientist I, Pharmaceutical Sciences
1998 – 1999
Key Colleagues at Startups
The people Jeb Keiper works with at each company, as listed on that company's latest Form D.
Strand Therapeutics Inc. · Form D, Mar 17, 2026
Ala Alenazi
Investment and director
Pegah Ebrahimi
Co-founder & Managing Partner, FPV Ventures, director
Tasuku Kitada
President, Head of R&D, Co-founder, director
Samta Kundu
Chief Operating Officer
Jory Bell
Director
Jacob Becraft
CEO, Co-Founder and director
Cardurion Pharmaceuticals, Inc. · Form D, Jul 24, 2024
ER
Evan Rachlin
Director
MM
Michael Mendelsohn
Executive officer and director
DL
Daniel Lynch
Director
ER
Emma Reeve
Director
PL
Peter Lawrence
President and Chief Executive Officer, director
EM
Edward Mathers
Director
AK
Adam Koppel
Director
ND
Nicholas Downing
Director